about
Cellular robustness conferred by genetic crosstalk underlies resistance against chemotherapeutic drug doxorubicin in fission yeastThe tell-tale heart: molecular and cellular responses to childhood anthracycline exposureMulti-Organ toxicity demonstration in a functional human in vitro system composed of four organs.Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specificEnzymatic methods for glyco(diversification/randomization) of drugs and small moleculesProbing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albuminsBerberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expressiontRNA binding to antitumor drug doxorubicin and its analogueMicrofluidic cell isolation technology for drug testing of single tumor cells and their clusters.Ultrasound/Magnetic Targeting with SPIO-DOX-Microbubble Complex for Image-Guided Drug Delivery in Brain Tumors.Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle.The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity.MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma.Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted miceEchinochrome A protects mitochondrial function in cardiomyocytes against cardiotoxic drugs.WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte deathMesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo.Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancerEffects of PPARα/PGC-1α on the myocardial energy metabolism during heart failure in the doxorubicin induced dilated cardiomyopathy in miceTherapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent ApoptosisDoxorubicin pathways: pharmacodynamics and adverse effects.Fitness profiling links topoisomerase II regulation of centromeric integrity to doxorubicin resistance in fission yeastIdentification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticlesABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Activation of microbubbles by low-level therapeutic ultrasound enhances the antitumor effects of doxorubicin.p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12.Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes.Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage"Two-Step" Raman Imaging Technique To Guide Chemo-Photothermal Cancer Therapy.Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads.Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1.The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with DoxorubicinDesign of Albumin-Coated Microbubbles Loaded With Polylactide Nanoparticles.A potential role for protein palmitoylation and zDHHC16 in DNA damage response.Quercetin induces cell cycle arrest and apoptosis in CD133(+) cancer stem cells of human colorectal HT29 cancer cell line and enhances anticancer effects of doxorubicin.Combination of glycosphingosomes and liposomal doxorubicin shows increased activity against dimethyl-α-benzanthracene-induced fibrosarcoma in mice.
P2860
Q21133734-4EF444B3-CF4B-492B-9CCC-5B9B29544260Q26823592-C8FDCD19-C9F8-477D-98B6-EB65349EFEAAQ27300308-7EA62045-E6A2-4237-876C-1BFABD650F2AQ27301261-F17DEE58-07B6-470F-91E5-62441A1B10FFQ28247479-59B78220-00CB-46A1-9ACE-452376FFE4ACQ28482550-C2E156D6-1C11-4667-A408-DCACF5878A8FQ28484395-05DDF184-0B70-4280-BE39-60E8F0E40C6AQ28534958-F97A1688-9FB6-4010-83E0-6C1FD1D3EA21Q30364122-7849D360-AB8E-4A93-97A4-0F005AE3C7E7Q30378616-A86E0836-330F-41BE-A42C-FE7A6C6BA98DQ30426977-69E1222C-686C-4551-8AC2-01CC1CFA529BQ33427938-81862B5F-8D10-4B52-B58F-53BB30813366Q33635350-DC3A17AD-EBED-46C8-A209-AAF9BAD88E18Q33727633-E986E6E1-12DA-458B-96C0-3058ED30C2B4Q33736748-C6607B65-EB92-4FE6-8C11-02AC7CE76621Q33913340-6CBA1D96-1B46-4C64-A1C4-194B7F3B2CE3Q34011106-BBCD08DB-DCFF-4EFC-84D5-2A07077BE336Q34160698-01666F75-34EF-482E-8BD9-6FC279B58946Q34292101-D2A97BCA-81F1-477B-8122-F6475C496BDCQ34414867-9DE60696-7DDE-41FB-84A9-BAFA1CD61E7CQ34417525-0FDE7D21-657F-4E6C-B76A-B5978C15D169Q34955313-EC824399-B397-4C6C-A3FA-525FD430F0BBQ35048393-035F52A6-F858-4B82-8C72-C5C4E41D68B1Q35070152-2E18EBBC-BD14-4A89-9EE4-8D70C46A63EAQ35078142-0E950082-060D-4FE2-9AEB-8FB29E163918Q35105148-806A93B3-310E-4B33-ACA2-4B8AF09BD400Q35171274-9DE43230-EAB7-4F5A-BBE9-B23B14DB1FC5Q35219985-A5F93265-2403-407C-AF05-0DD3C423F678Q35485832-ECEF08CB-583B-4C5D-AA96-3A9F388D488EQ35536301-EFCD50BC-CB57-41FE-85D5-5148FEC2C157Q35550223-9FBF8F76-76AF-408A-967E-F5D55700EE98Q35681478-A8537086-C4FA-498B-A687-8FB27DA23DB1Q35746469-E969815A-9900-45BE-A58C-E5F82EDDA457Q35843875-7DC3BE74-28B7-4119-8E34-B4A49EC3D095Q35868154-99CA0780-F305-42D1-BC10-F7221C94062AQ35890561-0F74B7EA-45C1-4E6A-910F-B466ECBD60C2Q35954495-8FF8AC7B-E14C-4242-AB36-EFDC7E4017CFQ36012474-DDAB8B3E-9727-4519-8E76-309ACB8E6971Q36017156-A2C18F87-A860-41F8-9A5D-02A01FB2EAB5Q36160398-4147F8BD-3926-4021-876A-748EBD3127AD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Doxorubicin: the good, the bad and the ugly effect.
@en
Doxorubicin: the good, the bad and the ugly effect.
@nl
type
label
Doxorubicin: the good, the bad and the ugly effect.
@en
Doxorubicin: the good, the bad and the ugly effect.
@nl
prefLabel
Doxorubicin: the good, the bad and the ugly effect.
@en
Doxorubicin: the good, the bad and the ugly effect.
@nl
P50
P1476
Doxorubicin: the good, the bad and the ugly effect.
@en
P2093
Maria S Santos
P304
P356
10.2174/092986709788803312
P577
2009-09-01T00:00:00Z